(Q44126264)

30 November 2017

title

Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation (English)

1 reference

30 November 2017

3

1 reference

30 November 2017

Sadler K

1

1 reference

30 November 2017

Zeng W

series ordinal

2

1 reference

30 November 2017

publication date

1 September 2002

1 reference

Chemical Biology and Drug Design

30 November 2017

published in

1 reference

30 November 2017

volume

60

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

150-158

1 reference

Preparation and properties of totally synthetic immunogens

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

A synthetic vaccine constructed by copolymerization of B and T cell determinants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

A synthetic peptide-based polyoxime vaccine construct of high purity and activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Orthogonal ligation strategies for peptide and protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Polymerization of Unprotected Synthetic Peptides: A View toward Synthetic Peptide Vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Free radical induced polymerization of synthetic peptides into polymeric immunogens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2002.21009.X

7 January 2021

10.1034/J.1399-3011.2002.21009.X

Identifiers

DOI

1 reference

30 November 2017

1 reference